Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

被引:0
|
作者
YKY Lai
WY Shen
M Brankov
CM Lai
IJ Constable
PE Rakoczy
机构
[1] Lions Eye Institute,Department of Molecular Ophthalmology
[2] Centre for Ophthalmology and Visual Science,undefined
[3] University of Western Australia,undefined
来源
Gene Therapy | 2002年 / 9卷
关键词
secretion gene therapy; vascular endothelial growth factor; sFlt-1; adeno-associated virus; ocular neovascularisation; inhibition;
D O I
暂无
中图分类号
学科分类号
摘要
Neovascularisation (NV) within the eye often results in visual loss. Vascular endothelial growth factor (VEGF) has been implicated in the development of ocular NV. Previous studies have shown that VEGF antagonists successfully suppressed retinal and choroidal NV in animal models. However, the systemic approach and transient nature of the delivery systems used in these studies hinder therapeutic application. To achieve stable and localised ocular anti-angiogenic therapy, we explored the use of recombinant adeno-associated virus (rAAV)-mediated secretion gene therapy (SGT). In this study, we generated a rAAV vector encoding soluble VEGF receptor 1, sFlt-1 (AAV-CMV.sflt) and determined its ability to inhibit cautery-induced corneal NV and laser-induced choroidal NV. Delivery of AAV-CMV.sflt into the anterior chamber resulted in transgene expression in the iris pigment epithelium and corneal endothelium, which reduced the development of corneal NV in the stroma of cauterised rats by 36% compared with cauterised control groups (P = 0.009). Subretinal delivery of AAV-CMV.sflt near the equator of the eye also suppressed choroidal NV at the laser lesions around the optic nerve by 19% (P = 0.002), indicating that there was diffusion of the secreted anti-angiogenic protein across the retina. Both results suggest that the long-term suppression of ocular NV is possible through the use of stable rAAV-mediated SGT.
引用
收藏
页码:804 / 813
页数:9
相关论文
共 50 条
  • [1] Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy
    Lai, YKY
    Shen, WY
    Brankov, M
    Lai, CM
    Constable, IJ
    Rakoczy, PE
    [J]. GENE THERAPY, 2002, 9 (12) : 804 - 813
  • [2] Ocular Gene Therapy: An Evaluation of Recombinant Adeno-Associated Virus-Mediated Gene Therapy Interventions for the Treatment of Ocular Disease
    Roy, Kamolika
    Stein, Linda
    Kaushal, Shalesh
    [J]. HUMAN GENE THERAPY, 2010, 21 (08) : 915 - 927
  • [3] Adeno-Associated Virus-Mediated Gene Therapy
    Zaman, Hassan
    Khan, Aakif
    Khan, Khalid
    Toheed, Shazma
    Abdullah, Muhammad
    Zeeshan, Hafiz Muhammad
    Hameed, Abdul
    Umar, Muhammad
    Shahid, Muhammad
    Malik, Kausar
    Afzal, Samia
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2023, 33 (06): : 87 - 100
  • [4] Kinetics of recombinant adeno-associated virus-mediated gene transfer
    Malik, AK
    Monahan, PE
    Allen, DL
    Chen, BG
    Samulski, RJ
    Kurachi, K
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (08) : 3555 - 3565
  • [5] Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer
    Park, J
    Murray, GJ
    Limaye, A
    Quirk, JM
    Gelderman, MP
    Brady, RO
    Qasba, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (06) : 3450 - 3454
  • [6] Adeno-associated virus-mediated gene therapy for cancer
    Collins, Sara
    Harrison, P. T.
    Scallan, M. F.
    O'Sullivan, Gerald C.
    Tangney, Mark
    [J]. HUMAN GENE THERAPY, 2007, 18 (10) : 999 - 999
  • [7] Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates
    Le Meur, G
    Weber, M
    Péréon, Y
    Mendes-Madeira, A
    Nivard, D
    Deschamps, JY
    Moullier, P
    Rolling, F
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (04) : 500 - 506
  • [8] Recombinant adeno-associated virus-mediated gene transfer for embryonic stem cell gene therapy
    Wei, FS
    Song, SH
    Loiler, S
    Cruz, P
    Conlon, T
    Wei, JF
    Zhao, G
    Flotte, TR
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 256A - 257A
  • [9] Adeno-Associated Virus-Mediated Gene Therapy for Metabolic Myopathy
    Mah, Cathryn S.
    Soustek, Meghan S.
    Todd, A. Gary
    McCall, Angela
    Smith, Barbara K.
    Corti, Manuela
    Falk, Darin J.
    Byrne, Barry J.
    [J]. HUMAN GENE THERAPY, 2013, 24 (11) : 928 - 936
  • [10] Adeno-associated virus-mediated gene therapy in cardiovascular disease
    Hammoudi, Nadjib
    Ishikawa, Kiyotake
    Hajjar, Roger J.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2015, 30 (03) : 228 - 234